The purpose of this cooperative agreement is to assist NMAC in expanding and enhancing its activities relevant to HIV prevention, services, treatment, and research in racial and ethnic minority populations, with the ultimate goal of improving the health status of minorities and disadvantaged people. Applicants may apply for either a Developing Center or a Comprehensive Center, however, not for both. 450, Rockville, MD 20852. Domestic public or private nonprofit organizations and for-profit organizations, including universities, colleges, hospitals, laboratories, units of state or local governments, and eligible agencies of the federal government. Foreign institutions are not eligible for an R03 award.
Small grants have special eligibility requirements.
Applicants for the Minority-Based CCOP must document that at least 40 percent of their newly diagnosed cancer patients are from minority populations. NCI is looking for domestic institutions with the capability and intent to serve new cancer patients largely from minority populations. The NCI clinical trials program provides a network of support for clinical research in cancer centers, major university centers, and community programs. The purpose of this program is to support as a national resource those physicians involved in the care of minority cancer patients who are available for treatment and prevention and control research. The linkage of minority cancer patients to the current clinical trials network will also facilitate the transfer of new technology in treatment and cancer prevention and control practices to minority communities and their physicians.